HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Dimethylnitrosamine (Nitrosodimethylamine)

A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties. It causes serious liver damage and is a hepatocarcinogen in rodents.
Also Known As:
Nitrosodimethylamine; N-Nitrosodimethylamine; NDMA Nitrosodimethylamine; N Nitrosodimethylamine; Nitrosodimethylamine, NDMA; Methanamine, N-methyl-N-nitroso-
Networked: 670 relevant articles (14 outcomes, 103 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Liu, Ping: 20 articles (01/2015 - 10/2003)
2. Liu, Cheng: 10 articles (01/2015 - 10/2003)
3. Pairojkul, Chawalit: 7 articles (11/2015 - 07/2011)
4. Pinlaor, Somchai: 7 articles (11/2015 - 10/2009)
5. Yongvanit, Puangrat: 7 articles (11/2015 - 05/2006)
6. Boonmars, Thidarut: 7 articles (03/2014 - 10/2009)
7. Wang, Lei: 6 articles (01/2015 - 11/2005)
8. Liu, Cheng-hai: 5 articles (03/2015 - 10/2003)
9. Pinlaor, Porntip: 5 articles (02/2014 - 07/2011)
10. Hong, Soon-Sun: 5 articles (01/2013 - 04/2009)

Related Diseases

1. Liver Cirrhosis (Hepatic Cirrhosis)
2. Fibrosis (Cirrhosis)
3. Necrosis
4. Neoplasms (Cancer)
5. Ascites

Related Drugs and Biologics

1. DNA (Deoxyribonucleic Acid)
2. Carbon Tetrachloride (Tetrachloromethane)
3. Thioacetamide (Thioacetamid)
4. Ethanol (Ethyl Alcohol)
5. Tea
6. resveratrol
7. Galactosamine
8. Anthocyanins (Anthocyanin)
9. Picibanil
10. Betaine (C.B.B.)

Related Therapies and Procedures

1. Intraperitoneal Injections
2. Aftercare (After-Treatment)
3. Ligation
4. Surgical Splenorenal Shunt (Splenorenal Shunt)
5. Surgical Portasystemic Shunt (Portosystemic Shunt)